Enhancement of Bordetella parapertussis infection by Bordetella pertussis in mixed infection of the respiratory tract

FEMS Immunology and Medical Microbiology

Volumn 63, Issue 1, 2011, Pages 119-128

  Worthington, Zoë E V ^a   van Rooijen, Nico ^b   Carbonetti, Nicholas H ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bordetella parapertussis; Bordetella pertussis; Mixed infection; Pertussis toxin; Respiratory infection

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BORDETELLA PARAPERTUSSIS; BORDETELLA PARAPERTUSSIS INFECTION; CONTROLLED STUDY; INNATE IMMUNITY; INOCULATION; LUNG LAVAGE; MIXED INFECTION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

ANIMALS; BORDETELLA INFECTIONS; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; COINFECTION; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED BALB C; MICROBIAL INTERACTIONS; RESPIRATORY TRACT INFECTIONS;

EID: 80052573468     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2011.00836.x     Document Type: Article

References (39)

1. Allen AG, Thomas RM, Cadisch JT & Maskell DJ (1998) Molecular and functional analysis of the lipopolysaccharide biosynthesis locus wlb from Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Mol Microbiol29: 27-38.
2. Andreasen C & Carbonetti NH (2008) Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice. Infect Immun76: 5139-5148.
3. Andreasen C & Carbonetti NH (2009) Role of neutrophils in response to Bordetella pertussis infection in mice. Infect Immun77: 1182-1188.
4. Arico B & Rappuoli R (1987) Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J Bacteriol169: 2847-2853.
5. Ayala VI, Teijaro JR, Farber DL, Dorsey SG & Carbonetti NH (2011) Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity. PLoS One6: e19016.
6. Carbonetti NH, Artamonova GV, Mays RM & Worthington ZE (2003) Pertussis toxin plays an early role in respiratory tract colonization by Bordetella pertussis. Infect Immun71: 6358-6366.
7. Carbonetti NH, Artamonova GV, Andreasen C, Dudley E, Mays RM & Worthington ZE (2004) Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein. Infect Immun72: 3350-3358.
8. Carbonetti NH, Artamonova GV, Andreasen C & Bushar N (2005) Pertussis toxin and adenylate cyclase toxin provide a one-two punch for establishment of Bordetella pertussis infection of the respiratory tract. Infect Immun73: 2698-2703.
9. Carbonetti NH, Artamonova GV, Van Rooijen N & Ayala VI (2007) Pertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tract. Infect Immun75: 1713-1720.
10. Caroff M, Aussel L, Zarrouk H, Martin A, Richards JC, Therisod H, Perry MB & Karibian D (2001) Structural variability and originality of the Bordetella endotoxins. J Endotoxin Res7: 63-68.
11. Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA & Mooi FR (2005) Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog1: e45.
12. Di Fabio JL, Caroff M, Karibian D, Richards JC & Perry MB (1992) Characterization of the common antigenic lipopolysaccharide O-chains produced by Bordetella bronchiseptica and Bordetella parapertussis. FEMS Microbiol Lett76: 275-281.
13. Ensminger PW (1953) Pigment production by Haemophilus parapertussis. J Bacteriol65: 509-510.
14. Fedele G, Nasso M, Spensieri F, Palazzo R, Frasca L, Watanabe M & Ausiello CM (2008) Lipopolysaccharides from Bordetella pertussis and Bordetella parapertussis differently modulate human dendritic cell functions resulting in divergent prevalence of Th17-polarized responses. J Immunol181: 208-216.
15. Feunou PF, Bertout J & Locht C (2010) T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis. PLoS One5: e10178.
16. Goebel EM, Wolfe DN, Elder K, Stibitz S & Harvill ET (2008) O antigen protects Bordetella parapertussis from complement. Infect Immun76: 1774-1780.
17. Heininger U, Stehr K, Schmitt-Grohe S, Lorenz C, Rost R, Christenson PD, Uberall M & Cherry JD (1994) Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J13: 306-309.
18. Heininger U, Cotter PA, Fescemyer HW, Martinez de Tejada G, Yuk MH, Miller JF & Harvill ET (2002) Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing. Infect Immun70: 3777-3784.
19. Iwata S, Aoyama T, Goto Aet al. (1991) Mixed outbreak of Bordetella pertussis and Bordetella parapertussis in an apartment house. Dev Biol Stand73: 333-341.
20. Katada T, Tamura M & Ui M (1983) The A protomer of islet-activating protein, pertussis toxin, as an active peptide catalyzing ADP-ribosylation of a membrane protein. Arch Biochem Biophys224: 290-298.
21. Kawai H, Aoyama T, Murase Y, Tamura C & Imaizumi A (1996) A causal relationship between Bordetella pertussis and Bordetella parapertussis infections. Scand J Infect Dis28: 377-381.
22. Kimura A, Mountzouros KT, Schad PA, Cieplak W & Cowell JL (1990) Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen. Infect Immun58: 3337-3347.
23. Kirimanjeswara GS, Agosto LM, Kennett MJ, Bjornstad ON & Harvill ET (2005) Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest115: 3594-3601.
24. Komatsu E, Yamaguchi F, Eguchi M & Watanabe M (2010) Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model. Vaccine28: 4362-4368.
25. Long GH, Karanikas AT, Harvill ET, Read AF & Hudson PJ (2010) Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis. Proc Biol Sci277: 2017-2025.
26. Mann PB, Wolfe D, Latz E, Golenbock D, Preston A & Harvill ET (2005) Comparative toll-like receptor 4-mediated innate host defense to Bordetella infection. Infect Immun73: 8144-8152.
27. Mattoo S & Cherry JD (2005) Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev18: 326-382.
28. Mertsola J (1985) Mixed outbreak of Bordetella pertussis and Bordetella parapertussis infection in Finland. Eur J Clin Microbiol4: 123-128.
29. Moss J, Stanley SJ, Burns DL, Hsia JA, Yost DA, Myers GA & Hewlett EL (1983) Activation by thiol of the latent NAD glycohydrolase and ADP-ribosyltransferase activities of Bordetella pertussis toxin (islet-activating protein). J Biol Chem258: 11879-11882.
30. Musser JM, Hewlett EL, Peppler MS & Selander RK (1986) Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol166: 230-237.
31. Parkhill J, Sebaihia M, Preston Aet al. (2003) Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet35: 32-40.
32. Porter JF, Connor K & Donachie W (1994) Isolation and characterization of Bordetella parapertussis-like bacteria from ovine lungs. Microbiology140(Part 2): 255-261.
33. Roorda L, Buitenwerf J, Ossewaarde JM & van der Zee A (2011) A real-time PCR assay with improved specificity for detection and discrimination of all clinically relevant Bordetella species by the presence and distribution of three insertion sequence elements. BMC Res Notes4: 11.
34. Tatti KM, Wu KH, Tondella ML, Cassiday PK, Cortese MM, Wilkins PP & Sanden GN (2008) Development and evaluation of dual-target real-time polymerase chain reaction assays to detect Bordetella spp. Diagn Micr Infec Dis61: 264-272.
35. Tsai WC, Strieter RM, Mehrad B, Newstead MW, Zeng X & Standiford TJ (2000) CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect Immun68: 4289-4296.
36. Van Rooijen N & Sanders A (1994) Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 174: 83-93.
37. Watanabe M & Nagai M (2004) Whooping cough due to Bordetella parapertussis: an unresolved problem. Expert Rev Anti Infect Ther 2: 447-454.
38. Witvliet MH, Burns DL, Brennan MJ, Poolman JT & Manclark CR (1989) Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect Immun57: 3324-3330.
39. Wolfe DN, Buboltz AM & Harvill ET (2009) Inefficient Toll-like receptor-4 stimulation enables Bordetella parapertussis to avoid host immunity. PLoS One4: e4280.